Cardiovascular safety of mirabegron add‐on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study
暂无分享,去创建一个
H. Kakizaki | O. Yamaguchi | Kyu-Sung Lee | T. Katoh | B. Sumarsono | K. Ishida | S. Uno | Daisuke Katou | O. Yamamoto | J. Jong